ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The main mark of CML is the Philadelphia chromosome, result of a genetic translocation that originates a fusion gene whose protein product is the chimerical BCR-ABL1 tyrosine kinase which is constitutively active.